Home » Siemens Gets FDA Marketing Clearance of the Xprecia Stride Coagulation Analyze Device
Siemens Gets FDA Marketing Clearance of the Xprecia Stride Coagulation Analyze Device
Siemens has received 510(k) clearance from the FDA for a hand-held portable coagulation analyzer.
The device uses fresh capillary whole blood, and results are expressed as an INR (international normalized ratio).
The Xprecia Stride device is the first point-of-care/INR device cleared by the FDA that meets the new rules published in March 2016. — Cynthia Jessup
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May